Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) (Q89337829)

1

0 references

Hou Yunlong

2

0 references

Huang Jicheng

3

0 references

Pan Weiqi

4

0 references

Ma Qinhai

5

0 references

Shi Yongxia

6

0 references

Li Chufang

7

0 references

Zhao Jin

8

0 references

Jia Zhenhua

9

0 references

Jiang Haiming

10

0 references

Zheng Kui

11

0 references

Huang Shuxiang

12

0 references

Dai Jun

13

0 references

Li Xiaobo

14

0 references

Hou Xiaotao

15

0 references

Wang Lin

16

0 references

Yang Zifeng

Clinical and laboratory findings of SARS in Singapore.

18

0 references

language of work or name

English

0 references

publication date

20 March 2020

0 references

published in

Pharmacological Research

0 references

page(s)

104761

0 references

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Coronaviruses - drug discovery and therapeutic options.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Human Coronavirus: Host-Pathogen Interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Outbreak of a novel coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Novel Wuhan (2019-nCoV) Coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

Traditional Chinese medicine for COVID-19 treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/32205232

12 December 2020

10.1016/J.PHRS.2020.104761

Identifiers

DOI

0 references

Dimensions Publication ID

1125794330

1 reference

Dimensions COVID-19 publications, datasets and clinical trials